RA
CBST

Royce & Associates’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Royce & Associates’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-197,980
Closed -$13.1M – 1449
2014
Q3 		$13.1M Sell
197,980
-13,620
-6% -$895K 0.04% 504
2014
Q2 		$14.8M Sell
211,600
-8,300
-4% -$565K 0.04% 517
2014
Q1 		$16.1M Sell
219,900
-87,900
-29% -$6.55M 0.05% 492
2013
Q4 		$21.2M Sell
307,800
-118,000
-28% -$7.64M 0.06% 379
2013
Q3 		$27.1M Buy
425,800
+97,600
+30% +$5.9M 0.08% 293
2013
Q2 		$15.9M Buy
+328,200
New +$16.1M 0.05% 435

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates's CBST Position: Q4 2014 in Review

Royce & Associates sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 197,980 shares — an estimated $13.1M sold.

Royce & Associates first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $27.1M in Q3 2013. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Royce & Associates reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Royce & Associates sold 197,980 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $13.1M.
  • Royce & Associates first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • Royce & Associates's CUBIST PHARMACEUTICALS INC position peaked at $27.1M in Q3 2013.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Royce & Associates's 13F filing for Q4 2014, filed 9 Feb 2015.